Metabolic Explorer Stock

Metabolic Explorer EBIT

Delisted

The EBIT of Metabolic Explorer (METEX.PA) as of Aug 1, 2026 is -43.76 M EUR. In the previous year, EBIT was 73.04 M EUR — a change of -159.91% (lower).

EBIT

-43.76 MEUR

YoY

-159.91%

Last updated:

In 2026, Metabolic Explorer's EBIT was -43.76 M EUR, a -159.91% increase from the 73.04 M EUR EBIT recorded in the previous year.

The Metabolic Explorer EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2019
-8.38 base
Jan 1, 2020
-9.65 base
Jan 1, 2021
73.04 base
Jan 1, 2022
-43.76 base
Jan 1, 2023 (e)
-31.93 base
Jan 1, 2024 (e)
-10.30 base
Jan 1, 2025 (e)
7.21 base
Jan 1, 2026 (e)
32.16 base
YEAREBIT (M EUR)
2026 est 32.16
2025 est 7.21
2024 est -10.30
2023 est -31.93
2022 -43.76
2021 73.04
2020 -9.65
2019 -8.38
2018 -5.03
2017 -11.10
2016 10.39
2015 -6.93
2014 -3.79
2013 -4.05
2012 -7.40
2011 -5.86
2010 -5.22
2009 -3.78
2008 -2.45
2007 -0.53
2006 1.78
2005 -2.25
2004 -1.11
Access this data via the Eulerpool API

Metabolic Explorer Revenue

Metabolic Explorer Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
350,000.00 EUR
-8.38 M EUR
-8.25 M EUR
Jan 1, 2020
50,000.00 EUR
-9.65 M EUR
-8.93 M EUR
Jan 1, 2021
169.69 M EUR
73.04 M EUR
82.62 M EUR
Jan 1, 2022
226.60 M EUR
-43.76 M EUR
-50.83 M EUR
Jan 1, 2023 (e)
135.96 M EUR
-31.93 M EUR
-37.75 M EUR
Jan 1, 2024 (e)
198.79 M EUR
-10.30 M EUR
-17.95 M EUR
Jan 1, 2025 (e)
260.59 M EUR
7.21 M EUR
-4.14 M EUR
Jan 1, 2026 (e)
425.90 M EUR
32.16 M EUR
64.19 M EUR

Metabolic Explorer Margins

Metabolic Explorer stock margins

The Metabolic Explorer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Metabolic Explorer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Metabolic Explorer.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
-0.63 %
-2,393.43 %
-2,355.71 %
Jan 1, 2020
-3,324.00 %
-19,304.00 %
-17,864.00 %
Jan 1, 2021
9.44 %
43.04 %
48.69 %
Jan 1, 2022
-0.63 %
-19.31 %
-22.43 %
Jan 1, 2023 (e)
-0.63 %
-23.48 %
-27.76 %
Jan 1, 2024 (e)
-0.63 %
-5.18 %
-9.03 %
Jan 1, 2025 (e)
-0.63 %
2.77 %
-1.59 %
Jan 1, 2026 (e)
-0.63 %
7.55 %
15.07 %

Metabolic Explorer Stock analysis

What does Metabolic Explorer do? Metabolic Explorer SA is a French biotechnology company that was founded in 1999. It is headquartered in Clermont-Ferrand, France and employs approximately 70 employees, including scientists and engineers. The company specializes in the development and production of natural raw materials that are used in various industries such as cosmetics, food, and pharmaceuticals. The business model of Metabolic Explorer is based on innovative biological technology that enables the production of novel bio-based molecules by optimizing the metabolic processes of microorganisms. These novel molecules have higher quality and efficiency than conventional raw materials, making them promising alternatives for various industries. The company has specialized in various business areas. One of the most important is the production of bio-based amino acids used in the cosmetics and food industries. Metabolic Explorer has developed a patented method for producing amino acids from renewable resources such as plants and bacteria. This allows for amino acids to be produced without the use of petrochemical raw materials, making them more environmentally friendly and sustainable alternatives. Another business area of Metabolic Explorer is the production of bio-based lactic acid. Lactic acid is an important raw material for the production of bio-polymers, such as PLA (polylactic acid), used in the packaging industry. Again, Metabolic Explorer has developed a patented technology for producing lactic acid from renewable resources. Metabolic Explorer is also involved in the research and development of bio-molecules. The company works closely with various research institutions to optimize its biological technologies and processes and develop new applications. The goal is to improve the production of bio-based molecules and reduce costs. An example of Metabolic Explorer's innovative products is bio-based nylon precursor. Nylon is typically produced from petrochemical raw materials, leading to high costs and environmental impact. However, Metabolic Explorer has developed a patented technology that allows for the production of bio-based precursors that can be used as raw materials for nylon production. These bio-based precursors are made from renewable resources and can enable a more environmentally friendly and sustainable nylon. Metabolic Explorer has a variety of partnerships and collaborations with companies in various industries. One example is the collaboration with food company Roquette to develop bio-based glycerin products. Another partnership is with cosmetics company L'Oréal to develop bio-based lactic acid for use in cosmetics. Overall, Metabolic Explorer specializes in the development and production of bio-based molecules that offer a promising alternative to conventional petrochemical raw materials. With its patented biological technologies, the company is well-positioned to make a significant contribution to sustainability in various industries. Metabolic Explorer is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Metabolic Explorer's EBIT

Metabolic Explorer's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Metabolic Explorer's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Metabolic Explorer's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Metabolic Explorer’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Metabolic Explorer stock

EBIT of Metabolic Explorer is -43.76 M EUR in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Metabolic Explorer

All Key Metrics — Metabolic Explorer